A potential role for glucagon in the treatment of drug-induced symptomatic bradycardia

Chest

Volumn 114, Issue 1, 1998, Pages 323-326

  Love, Jeffrey N ^a   Sachdeva, Deepak K ^a   Bessman, Edward S ^b   Curtis, Liesl A ^a   Howell, John M ^a  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Beta adrenergic blockers; Bradycardia; Glucagon

Indexed keywords

ATENOLOL; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHLORIDE; DIGOXIN; DILTIAZEM; DOPAMINE; ENALAPRIL MALEATE; GLUCAGON; METHYLDOPA; METOPROLOL; NADOLOL; PROPRANOLOL; TIMOLOL; VERAPAMIL;

ADULT; AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BRADYCARDIA; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG INDICATION; DRUG MECHANISM; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 0031869787     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.1.323     Document Type: Article

References (11)

1. Love JN, Howell JM. Glucagon therapy in the treatment of symptomatic bradycardia. Ann Emerg Med 1997; 29: 181-83
2. Lipski JI, Kaminsky D, Donoso E, et al. Electrophysiological effects of glucagon on the normal canine heart. Am J Physiol 1972; 222:1107-12
3. Weinstein RS. Recognition and management of poisoning with beta adrenergic blocking agents. Ann Emerg Med 1984; 13:1123-31
4. Love JN, Leasure JA, Mundt DJ, et al. A comparison of amrinone and glucagon therapy for cardiovascular depression associated with propranolol toxicity in a canine model. J Toxicol Clin Toxicol 1992; 30:399-412
5. Lucchesi BR. Cardiac actions of glucagon. Circ Res 1968; 22:777-87
6. Love JN, Leasure JA, Mundt DJ. A comparison of combined amrinone and glucagon therapy to glucagon alone for cardiovascular depression associated with propranolol toxicity. Am J Emerg Med 1993; 11:360-63
7. Armstrong PW, Gold HK, Daggett WM, et al. Hemodynamic evaluation of glucagon in symptomatic heart disease. Circulation 1971; 44:67-73
8. Lvoff R, Wilcken DEL. Glucagon in heart failure and in cardiogenic shock: experience in 50 patients. Circulation 1972; 45:534-42
9. Love JN, Tandy TK. Beta adrenoreceptor antagonist toxicity: a survey of glucagon availability [letter]. Ann Emerg Med 1993; 22:267-68
10. Frishman W, Jacob H, Eisenberg E, et al. Clinical pharmacology of the new beta-adrenergic blocking drugs: part 8. Self-poisoning with beta-adrenoceptor blocking agents: recognition and management. Am Heart J 1979; 98:798-811
11. Mofenson HC, Caraccio TR, Laudano J. Glucagon for propranolol overdose [letter]. JAMA 1986; 255:2025